» Articles » PMID: 34873972

Aberrant Activation of the Hedgehog Signaling Pathway in Granulosa Cells from Patients with Polycystic Ovary Syndrome

Overview
Journal Bioengineered
Date 2021 Dec 7
PMID 34873972
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

The molecular mechanism that triggers polycystic ovary syndrome (PCOS) is mysterious. Abnormal development of ovarian granulosa cells (GCs) is one of the causes of PCOS. Herein, our study was carried out using RNA-seq to detect the different gene expression levels in ovarian GCs between three patients with PCOS and four normal controls. To verify the RNA-seq data, GCs from 22 patients with PCOS and 21 controls with normal ovulation were collected to perform the RT-PCR analysis. Hedgehog signaling pathway (Hh) members, Ihh and Ptch2 were abnormally highly expressed in the PCOS tissue (PT). The qPCR also indicated that the expression levels of Hh signaling pathway downstream members, Ptch1, Gli1, and Gli2 in the PT were significantly higher than those in the normal tissue (NT). Besides, the expression of TNF-α mRNA in PCOS patients was higher than that in the control group. Through the chromatin immunoprecipitation assay (ChIP), we found that the Gli1-IP-DNA enriched from the granular cells of PCOS patients was higher than that of the control group. Finally, the Hh signaling pathway inhibitor, cyclopamine, can decrease the apoptosis of PCOS ovarian granulosa cells. These results suggest that abnormal activation of Hh signaling pathway, especially Ihh signal, may have a profound influence on PCOS.

Citing Articles

The regulatory roles of Smad2/3 protein and gene expression in granulosa cells of germinal vesicle and metaphase II oocytes in polycystic ovarian syndrome: A case-control study.

Ghorbani M, Farimani M, Khodadadi I, Mohagheghi S, Amiri I, Tayebinia H Int J Reprod Biomed. 2024; 22(6):441-450.

PMID: 39205921 PMC: 11347763. DOI: 10.18502/ijrm.v22i6.16794.


Signaling pathways and targeted therapeutic strategies for polycystic ovary syndrome.

Wang K, Li Y Front Endocrinol (Lausanne). 2023; 14:1191759.

PMID: 37929034 PMC: 10622806. DOI: 10.3389/fendo.2023.1191759.


Current Advances in Cellular Approaches for Pathophysiology and Treatment of Polycystic Ovary Syndrome.

Tsai Y, Liao Y, Kang H Cells. 2023; 12(17).

PMID: 37681921 PMC: 10487183. DOI: 10.3390/cells12172189.


Cumulus Cell Transcriptome after Cumulus-Oocyte Complex Exposure to Nanomolar Cadmium in an In Vitro Animal Model of Prepubertal and Adult Age.

Martino N, Picardi E, Ciani E, DErchia A, Bogliolo L, Ariu F Biology (Basel). 2023; 12(2).

PMID: 36829526 PMC: 9953098. DOI: 10.3390/biology12020249.


Predictive value of serum anti-endometrium antibody level in infertile patients with polycystic ovary syndrome.

Sang M, Yu Y, Zhou Z, Zhang Y, Chang H Ir J Med Sci. 2022; 192(5):2167-2172.

PMID: 36411377 DOI: 10.1007/s11845-022-03219-z.

References
1.
Ma X, Li X, Ma L, Chen Y, He S . Soy isoflavones alleviate polycystic ovary syndrome in rats by regulating NF- κB signaling pathway. Bioengineered. 2021; 12(1):7215-7223. PMC: 8806892. DOI: 10.1080/21655979.2021.1979864. View

2.
Setji T, Brown A . Polycystic ovary syndrome: update on diagnosis and treatment. Am J Med. 2014; 127(10):912-9. DOI: 10.1016/j.amjmed.2014.04.017. View

3.
Nilsson E, Skinner M . Cellular interactions that control primordial follicle development and folliculogenesis. J Soc Gynecol Investig. 2001; 8(1 Suppl Proceedings):S17-20. DOI: 10.1016/s1071-5576(00)00099-x. View

4.
Parrott J, Skinner M . Thecal cell-granulosa cell interactions involve a positive feedback loop among keratinocyte growth factor, hepatocyte growth factor, and Kit ligand during ovarian follicular development. Endocrinology. 1998; 139(5):2240-5. DOI: 10.1210/endo.139.5.6018. View

5.
Japur C, Diez-Garcia R, Penaforte F, Sa M . Imbalance Between Postprandial Ghrelin and Insulin Responses to an Ad Libitum Meal in Obese Women With Polycystic Ovary Syndrome. Reprod Sci. 2014; 21(8):1020-1026. PMC: 4126217. DOI: 10.1177/1933719114522521. View